News
Research Report on China”s Anti-Prostatic Hyperplasia (PH) Drug Market, 2013-2017
Research and Markets has announced the addition of the "Research Report on China''s Anti-Prostatic Hyperplasia (PH) Drug Market, 2013-2017" report to their offering.Benign prostatic hyperplasia...
News
Apollo Hospitals Accomplishes yet Another Feat With Robotic Spine Surgery in the City
In line with its recent achievements in the field of onco-robotics, Apollo Hospitals has again proved itself to be a desired medical tourism destination with...
News
Astute Medical, Inc. To Host Educational Symposium At Critical Care Nephrology Meeting
Astute Medical, Inc. will host an educational symposium bringing together an international panel of medical experts to discuss how newly validated biomarkers of acute kidney...
News
WebPT Launches Functional Limitation Reporting Feature
WebPT, a web-based electronic medical record (EMR) solution for physical therapists (PTs), occupational therapists (OTs) and speech-language pathologists (SLPs), is excited to announce the launch...
News
Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis
Whole-cell pertussis vaccines were more effective at protecting against pertussis than acellular pertussis vaccines during a large recent outbreak, according to a new Kaiser Permanente...
News
OrbusNeich obtains additional preliminary injunction against Boston Scientific in Germany
OrbusNeich Medical Inc. and its subsidiary, OrbusNeich Medical GmbH (collectively, "OrbusNeich"), today announced that the Dusseldorf Regional Court has issued a second preliminary injunction against...
News
Creabilis Announces Headline Results of its Phase 2b Trial of Topical TrkA Kinase Inhibitor CT327
Creabilis, a late stage European dermatology company with a focus on chronic pruritus (itch), today announces headline results of its Phase 2b trial with its...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.

















